New NeuroStar Transcranial Magnetic Stimulation Therapy System for Depression Cleared by FDA | Medgadget

Neuronetics, a firm based in Malvern, Pennsylvania, won FDA approval for its latest NeuroStar transcranial magnetic stimulation therapy system. Approved in the U.S. for treating depression in patients who have tried at least one antidepressant drug, the new system has the major benefit of offering the same therapy during shorter sessions.

Read more
Hi there - can I help you with anything?
[Subscribe here]